1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
EFTA00810576
ext twelve months, including NDA filing for Tamsulosin, VERU-944 Phase 2 initiation and data, and VERU-111 IND filing and data. Solifenacin DRG and TadalafillFinasteride combo capsules NDA filing is expected in 2019. Equity Research Kmr I' ll' PhD Dir or nior Bi hnology Analyst Brookline Capital Markets Tradi
No connected entities